ATE86994T1 - Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen. - Google Patents

Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.

Info

Publication number
ATE86994T1
ATE86994T1 AT88909452T AT88909452T ATE86994T1 AT E86994 T1 ATE86994 T1 AT E86994T1 AT 88909452 T AT88909452 T AT 88909452T AT 88909452 T AT88909452 T AT 88909452T AT E86994 T1 ATE86994 T1 AT E86994T1
Authority
AT
Austria
Prior art keywords
resistant cells
methothrexate
inhibitors
ornithine derivatives
ornithine
Prior art date
Application number
AT88909452T
Other languages
English (en)
Inventor
Andre Rosowsky
Henry Bader
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE86994T1 publication Critical patent/ATE86994T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT88909452T 1987-11-04 1988-10-12 Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen. ATE86994T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/117,212 US4767761A (en) 1987-11-04 1987-11-04 Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
EP88909452A EP0345308B1 (de) 1987-11-04 1988-10-12 Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen
PCT/US1988/003545 WO1989004312A1 (en) 1987-11-04 1988-10-12 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells

Publications (1)

Publication Number Publication Date
ATE86994T1 true ATE86994T1 (de) 1993-04-15

Family

ID=22371547

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909452T ATE86994T1 (de) 1987-11-04 1988-10-12 Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.

Country Status (7)

Country Link
US (1) US4767761A (de)
EP (1) EP0345308B1 (de)
JP (1) JPH02502095A (de)
AT (1) ATE86994T1 (de)
CA (1) CA1316533C (de)
DE (1) DE3879478T2 (de)
WO (1) WO1989004312A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
DE3833393A1 (de) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel
US4956461A (en) * 1988-10-19 1990-09-11 Dana Farber Cancer Institute, Inc. Desamino-aminopterin and -methotrexate
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
EP0530537B1 (de) * 1991-08-12 1997-01-08 Takeda Chemical Industries, Ltd. Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
US20050032807A1 (en) * 2003-08-06 2005-02-10 Rosenwald Lindsay A. Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives
WO2006113536A2 (en) * 2005-04-14 2006-10-26 Hana Biosciences, Inc. Use of pt523 for treating cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393064A (en) * 1976-03-05 1983-07-12 Sri International Process and composition for treatment of leukemia and process for preparing the same
US4374987A (en) * 1980-08-14 1983-02-22 American Cyanamid Company Process for the preparation of high purity methotrexate and derivatives thereof
US4490529A (en) * 1983-09-06 1984-12-25 Dana-Farber Cancer Institute, Inc. Cysteic acid and homocysteic acid analogues of methotrexate and aminopterin
US4628090A (en) * 1984-08-21 1986-12-09 Rensselaer Polytechnic Institute Fluorine-containing antifolates incapable of polyglutanayte formation related compounds

Also Published As

Publication number Publication date
JPH0450314B2 (de) 1992-08-13
EP0345308A4 (de) 1990-05-14
DE3879478T2 (de) 1993-06-24
US4767761A (en) 1988-08-30
EP0345308A1 (de) 1989-12-13
DE3879478D1 (de) 1993-04-22
CA1316533C (en) 1993-04-20
JPH02502095A (ja) 1990-07-12
WO1989004312A1 (en) 1989-05-18
EP0345308B1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
HUP0003929A2 (hu) Piperazinszármazékok és alkalmazásuk gyulladásgátló hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
IL75070A0 (en) 6-aryl-3(2h)pyridazinones,processes for the preparation thereof and pharmaceutical compositions containing the same
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
ATE70268T1 (de) Stickstoffhaltige heterocyclen.
DE3577442D1 (de) Substituierte propanphosphonigsaeure-verbindungen.
HUP0004259A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények
ES8802049A1 (es) Procedimiento para preparar derivados de imidazo(1,5-a)piridina
ATE65994T1 (de) Insektentoetende pyrazoline.
NO910958L (no) Nye cc-1065-analoger med to cpi-underenheter.
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ATE86994T1 (de) Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.
ES8705372A1 (es) Un procedimiento para la preparacion de derivados monoamidi-cos de etilendiamina
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8500107L (sv) Nya 8-alfa-acylaminoergoline
ES2000456A6 (es) Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
ATE211482T1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
ES8506651A1 (es) Un metodo de preparar fenilalquil(piperazinil u homopiperazinil)propil-(ureas y tioureas) sustituidas
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
DE59010865D1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
ES8702379A1 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.